References
- Benson MD, Uemichi T. Transthyretin amyloidosis. Amyloid 1996;3:44–56.
- Kawaji T, Ando Y, Ando E, Sandgren O, Suhr OB, Tanihara H. Transthyretin-related vitreous amyloidosis in different endemic areas. Amyloid 2010;17:105–108.
- Hitchings RA, Tripathi RC. Vitreous opacities in primary amyloid disease. Br J Ophthalmol 1976;60:40–54.
- Sandgren O. Ocular amyloidosis, with special reference to the hereditary forms with vitreous involvement. Surv Ophthalmol 1995;40:173–196.
- Talmud P, Tybjaerg-Hansen A, Bhatnagar D, Mbewu A, Miller JP, Durrington P, Humphries S. Rapid screening for specific mutations in patients with a clinical diagnosis of familial hypercholesterolaemia. Atherosclerosis 1991;89:137–141.
- Booth DR, Tan SY, Hawkins PN, Pepys MB, Frustaci A. A novel variant of transthyretin, 59Thr–>Lys, associated with autosomal dominant cardiac amyloidosis in an Italian family. Circulation 1995;91:962–967.
- Patrosso MC, Salvi F, De Grandis D, Vezzoni P, Jacobson DR, Ferlini A. Novel transthyretin missense mutation (Thr34) in an Italian family with hereditary amyloidosis. Am J Med Genet 1998;77:135–138.
- Dunlop AA, Graham SL. Familial amyloidotic polyneuropathy presenting with rubeotic glaucoma. Clin Experiment Ophthalmol 2002;30:300–302.
- Kawaji T, Ando Y, Nakamura M, Yamashita T, Wakita M, Ando E, Hirata A, Tanihara H. Ocular amyloid angiopathy associated with familial amyloidotic polyneuropathy caused by amyloidogenic transthyretin Y114C. Ophthalmology 2005;112:2212.